Lambs immunized with an inactivated variant of Anaplasma phagocytophilum |
| |
Authors: | Snorre Stuen Wenche Okstad Karin Artursson Basima Al-Khedery Anthony Barbet Erik G Granquist |
| |
Affiliation: | .Department of Production Animal Clinical Sciences, Norwegian University of Life Sciences, Kyrkjevegen 332/334, 4325 Sandnes, Norway ;.Department of Bacteriology, National Veterinary Institute, SE-751 89 Uppsala, Sweden ;.Department of Infectious Diseases and Pathology, University of Florida, Gainesville, FL 32611 USA ;.Department of Production Animal Clinical Sciences, Norwegian University of Life Sciences, PO Box 8144, 0033 Oslo, Norway |
| |
Abstract: | BackgroundAnaplasma phagocytophilum (formerly Ehrlichia phagocytophila) is an obligate intracellular bacterium causing the disease tick-borne fever (TBF) in domestic ruminants. An effective vaccine against the infection has been demanded for livestock by sheep farmers and veterinary practitioners for years.FindingsIn the present study, we immunized lambs with an inactivated suspension of 1 × 108 killed A. phagocytophilum organisms mixed with adjuvant (Montanide ISA 61VG; Seppic). Twelve 9-months-old lambs of the Norwegian White Sheep breed were used. A full two-dose series of immunization was given subcutaneously to six lambs with a 4 week interval between injections. One month after the last immunization, all lambs were challenged with the homologous viable variant of A. phagocytophilum. After challenge, all lambs showed clinical responses for several days, although the immunized lambs reacted with an anamnestic response, i.e. significant reduction in infection rate and a significantly higher antibody titer.ConclusionImmunization with inactivated A. phagocytophilum did not protect lambs TBF. |
| |
Keywords: | Anaplasma phagocytophilum Immunization Sheep |
|
|